The Experts below are selected from a list of 15 Experts worldwide ranked by ideXlab platform
L R Ranganath - One of the best experts on this subject based on the ideXlab platform.
-
Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment.
2018Co-Authors: As Davison, Norman B, Am Milan, At Hughes, Khedr M, Rovensky J, L R RanganathAbstract:BackgroundOne of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of Normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone.Materials and methods24 h urinary excretions of NMA, MA, 3-MT and 5-HIAA were determined by liquid chromatography tandem mass spectrometry. Interassay coefficient of variation was ResultsUrine samples were assayed at baseline (pre-nitisinone, n = 36) and 4 weeks later; 7 received no nitisinone (4 male, mean age (±SD) 46.3 (16.4) years), and 29 received a daily dose of nitisinone [1 mg (n = 7, 6 male, mean age 45.9 (10.9) years), 2 mg (n = 8, 5 male, mean age 43.9 (13.7) years), 4 mg (n = 8, 5 male, mean age 47.3 (10.7) years) and 8 mg (n = 6, 4 male, mean age 53.8 (8.3) years)]. 3-MT concentrations increase significantly (p ConclusionsThis study shows that catecholamine and serotonin metabolism is altered by treatment with nitisinone
-
assessment of the effect of once daily nitisinone therapy on 24 h urinary metadrenalines and 5 hydroxyindole acetic acid excretion in patients with alkaptonuria after 4 weeks of treatment
2017Co-Authors: Andrew S Davison, Andrew T. Hughes, Brendan P Norman, Milad Khedr, Anna M. Milan, J Rovensky, L R RanganathAbstract:Background: One of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of Normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone.
Andrew S Davison - One of the best experts on this subject based on the ideXlab platform.
-
assessment of the effect of once daily nitisinone therapy on 24 h urinary metadrenalines and 5 hydroxyindole acetic acid excretion in patients with alkaptonuria after 4 weeks of treatment
2017Co-Authors: Andrew S Davison, Andrew T. Hughes, Brendan P Norman, Milad Khedr, Anna M. Milan, J Rovensky, L R RanganathAbstract:Background: One of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of Normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone.
As Davison - One of the best experts on this subject based on the ideXlab platform.
-
Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment.
2018Co-Authors: As Davison, Norman B, Am Milan, At Hughes, Khedr M, Rovensky J, L R RanganathAbstract:BackgroundOne of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of Normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone.Materials and methods24 h urinary excretions of NMA, MA, 3-MT and 5-HIAA were determined by liquid chromatography tandem mass spectrometry. Interassay coefficient of variation was ResultsUrine samples were assayed at baseline (pre-nitisinone, n = 36) and 4 weeks later; 7 received no nitisinone (4 male, mean age (±SD) 46.3 (16.4) years), and 29 received a daily dose of nitisinone [1 mg (n = 7, 6 male, mean age 45.9 (10.9) years), 2 mg (n = 8, 5 male, mean age 43.9 (13.7) years), 4 mg (n = 8, 5 male, mean age 47.3 (10.7) years) and 8 mg (n = 6, 4 male, mean age 53.8 (8.3) years)]. 3-MT concentrations increase significantly (p ConclusionsThis study shows that catecholamine and serotonin metabolism is altered by treatment with nitisinone
Andrew T. Hughes - One of the best experts on this subject based on the ideXlab platform.
-
assessment of the effect of once daily nitisinone therapy on 24 h urinary metadrenalines and 5 hydroxyindole acetic acid excretion in patients with alkaptonuria after 4 weeks of treatment
2017Co-Authors: Andrew S Davison, Andrew T. Hughes, Brendan P Norman, Milad Khedr, Anna M. Milan, J Rovensky, L R RanganathAbstract:Background: One of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of Normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone.
Brendan P Norman - One of the best experts on this subject based on the ideXlab platform.
-
assessment of the effect of once daily nitisinone therapy on 24 h urinary metadrenalines and 5 hydroxyindole acetic acid excretion in patients with alkaptonuria after 4 weeks of treatment
2017Co-Authors: Andrew S Davison, Andrew T. Hughes, Brendan P Norman, Milad Khedr, Anna M. Milan, J Rovensky, L R RanganathAbstract:Background: One of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of Normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone.